The Global Cell based assay Market has been estimated at USD XX billion in 2015 and is projected to reach USD XX billion by 2020, at a CAGR of XX% during the forecast period from 2015 to 2021. Cell-based assays have always been a powerful tool in the research lab. They can be designed to measure virtually any cellular or biochemical function.
Cell based assays are incredibly versatile and are now rapidly moving out of the lab into industry and into the clinics. They are designed to target specific cells using antibodies or other moieties, to determine the functionality and efficacy of drugs.
The global cell based assay market is driven by the increasing investments in drug discovery, increased adoption of high throughput screening methods, rapid technological advances, increase in the cell based research activities and the development in the automation and non-invasive methods of monitoring. However, the market is restrained by the high on maintenance and operational costs, lack of skilled personnel who can handle the technology and the increasing intellectual property rights issues that restricts innovations of the technology.
The global cell based assay market can be broadly segmented based on the type of product, technology, application and the end users.
Based on the type of products the market is further segmented as cell lines (primary cell lines, stem cell lines, immortalized cell lines), assay ready kits, cell culture kits, reagents and consumables, ligands and inhibitors.
Based on technology it is segmented into automated handling, flow cytometry, label free detection, high content screening and high throughput screening. Based on application it is segmented into drug discovery, ADME Research and others. Based on the end users it is segmented as academia, biotechnology, pharmaceuticals and clinical research organizations.
Based on geographical location, the cell based assay market can be divided into North America (USA, Canada and Mexico), Europe (France, UK, Germany, Spain, Portugal, Scandinavia, BENELUX, Italy), Asia-Pacific (India, China, Japan, South Korea, Australia, New Zealand), Middle East and Africa (GCC, Egypt) and Latin America (Brazil, and Argentina).
The increase in adoption of label-free cell based assay and the potentiality of the technology to identify and evaluate drugs for cancer are some of the opportunities for the market to grow. However, the difficulty to maintain the cell lines and lack of end user awareness in developing countries are some of the challenges for the market players. The key market vendors are Ametek, Inc., Bio-Rad Laboratories, Roche Diagnostics, GE Healthcare among many others.
Market analysis for the global Cell based assay market, with region specific assessments and competition analysis.
Market definition along with the identification of key drivers and restraints.
Identification of factors instrumental in changing the market scenarios, rising prospective opportunities, and identification of key companies that can influence this market on a global and regional scale
Extensively researched competitive landscape section with profiles of major companies along with their market shares
Identification and analysis of the macro and micro factors that affect the Global Cell Based Assay Market
A comprehensive list of key market players along with the analysis of their current strategic interests and key financial information
A wide-ranging knowledge and insights about the major players in this industry and the key strategies adopted by them to sustain and grow in the studied market
Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
Manager – Partner Relations & International Marketing
Ph: +1-214-377-1121 (US)/ +44-020-3286-9338 (UK)